Sotalol Hydrochloride Tablet
Product Images NDC 71610-849

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0849 80)

Sotalol Hydrochloride 80 mg oral tablet carton label showing 180 tablets per package. The label includes storage instructions to keep the product between 20 to 25 degrees Celsius in a light-resistant container. Manufactured in Toronto, Ontario, and packaged by Aphena Pharma, Cookeville, TN. The label indicates Rx only and provides NDC 71610-849-80 along with lot, serial, batch, and expiration fields.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure.jpg (Figure)

A line graph depicting Age Factor on the vertical axis versus Age in months on the horizontal axis, ranging from 0.1 to 50 months. The graph shows an increasing curve starting near 0.2 at 0.1 months and gradually rising to 1.0 at 24 months and beyond, indicating Age Factor progression with age.*

FDA Label Image

Figure2study1.jpg (Figure2study1)

A survival curve chart showing recurrence-free survival over time in days, comparing oral Sotalol at doses of 80 mg, 120 mg, and 160 mg to placebo. The chart includes p-values for the log-rank test at each dose level, indicating statistical comparison between Sotalol doses and placebo.*

FDA Label Image

Figure3study2.jpg (Figure3study2)

A Kaplan-Meier survival curve chart showing recurrence-free survival over time in days comparing oral Sotalol Hydrochloride AF and placebo. The vertical axis represents recurrence-free survival probability from 0.0 to 1.0, while the horizontal axis covers time up to 180 days. The chart includes a p-value of 0.002 from the Log-Rank test indicating statistical comparison between the two groups, with Sotalol Hydrochloride AF showing higher survival than placebo.*

FDA Label Image

Structur.jpg (Structurefigure)

Chemical structure of Sotalol Hydrochloride showing its molecular arrangement including a sulfonamide group, aromatic ring, hydroxyl group, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.